What We Do

The landscape of drug development is continuously evolving focusing on the development of novel biologics like PEPTIDES, BIOLOGICS, OLIGOS & NBCDs as therapeutic agents. These compounds have shown to offer targeted treatment options across a wide range of diseases, including genetic disorders, cancers, and metabolic diseases. However, the development of these therapeutic agents presents unique challenges, particularly in the realms of Analytical Characterization and Immunogenicity Assessment. These challenges are further underscored by recent changes and recommendations from regulatory bodies such as the FDA/EMA etc, which continuously updates its guidelines to ensure the safety, efficacy, and quality of these therapeutics.

Given the dynamic, evolving landscapes and the inherent complexities associated with the development of these therapeutic molecules, specialized consulting services in Analytical and Immunogenicity studies of the same have become increasingly vital. These services not only aid in the strategic and efficient development of innovative therapeutics but also facilitating compliance with complex and evolving regulatory requirements.